Josefina Linares
Overview
Explore the profile of Josefina Linares including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
85
Citations
1394
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Calvo-Silveria S, Gonzalez-Diaz A, Grau I, Marimon J, Cercenado E, Quesada M, et al.
Lancet Reg Health Eur
. 2024 May;
41:100913.
PMID: 38737571
Background: Invasive pneumococcal disease due to serotype 3 (S3-IPD) is associated with high mortality rates and long-term adverse effects. The introduction of the 13-valent pneumococcal conjugate vaccine (PCV13) into the...
2.
Camara J, Grau I, Gonzalez-Diaz A, Tubau F, Calatayud L, Cubero M, et al.
J Antimicrob Chemother
. 2020 Nov;
76(2):507-515.
PMID: 33254238
Objectives: To analyse the clonal dynamics and clinical characteristics of adult invasive pneumococcal disease (IPD) caused by MDR and penicillin-non-susceptible (PNS) pneumococci in Spain. Methods: All adult IPD episodes were...
3.
Canton R, Oliver A, Alos J, de Benito N, Bou G, Campos J, et al.
Enferm Infecc Microbiol Clin (Engl Ed)
. 2019 Mar;
38(4):182-187.
PMID: 30878313
Automated antimicrobial susceptibility testing devices are widely implemented in clinical microbiology laboratories in Spain, mainly using EUCAST (European Committee on Antimicrobial Susceptibility Testing) breakpoints. In 2007, a group of experts...
4.
Fenoll A, Ardanuy C, Linares J, Cercenado E, Marco F, Fleites A, et al.
Vaccine
. 2018 Nov;
36(52):7993-8000.
PMID: 30449634
Serotypes/genotypes causing invasive pneumococcal disease (IPD) in adults are determined by vaccination strategies. The aim of this study was to assess the epidemiology of IPD in adults (≥18 years) after...
5.
Moleres J, Fernandez-Calvet A, Ehrlich R, Marti S, Perez-Regidor L, Euba B, et al.
mBio
. 2018 Sep;
9(5).
PMID: 30254117
Tracking bacterial evolution during chronic infection provides insights into how host selection pressures shape bacterial genomes. The human-restricted opportunistic pathogen nontypeable (NTHi) infects the lower airways of patients suffering chronic...
6.
Shoji H, Vazquez-Sanchez D, Gonzalez-Diaz A, Cubero M, Tubau F, Santos S, et al.
Infect Drug Resist
. 2018 Sep;
11:1387-1400.
PMID: 30214260
Background: is an important pathogen in chronic obstructive pulmonary disease (COPD). We aimed at showing the recent changes in the epidemiology of pneumococcal diseases in patients with COPD, especially after...
7.
Camara J, Cubero M, Martin-Galiano A, Garcia E, Grau I, Nielsen J, et al.
J Antimicrob Chemother
. 2018 Aug;
73(11):2941-2951.
PMID: 30165641
Objectives: To analyse the epidemiology and genetic evolution of PMEN3 (Spain9V-156), a penicillin-non-susceptible clone of Streptococcus pneumoniae, causing invasive pneumococcal disease (IPD) in Barcelona during 1987-2016. Methods: WGS was performed...
8.
Cubero M, Grau I, Tubau F, Pallares R, Dominguez M, Linares J, et al.
Microb Drug Resist
. 2017 Dec;
24(7):949-957.
PMID: 29227744
Molecular epidemiology of Klebsiella pneumoniae bacteremic strains allows for a better understanding of preventive and therapeutic strategies. Clinical and microbiological characteristics of 348 K. pneumoniae bacteremia cases (2007-2009) were retrospectively...
9.
Shoji H, Domenech A, Simonetti A, Gonzalez A, Garcia-Somoza D, Cubero M, et al.
J Clin Microbiol
. 2017 Dec;
56(2).
PMID: 29212700
Little is known about the sensitivity of the BinaxNOW pneumococcal urinary antigen (PUA) test for adult pneumococcal pneumonia caused by different serotypes. In this study, we aimed to analyze the...
10.
Millares L, Marti S, Ardanuy C, Linares J, Santos S, Dorca J, et al.
Int J Chron Obstruct Pulmon Dis
. 2017 Oct;
12:2807-2811.
PMID: 29033561
Background: The bronchial mucosa is protected by a specialized immune system focused on the prevention of colonization and infection by potentially pathogenic microorganisms (PPMs). Immunoglobulin A (IgA) is the principal...